Aspire BioPharma, Inc. (ASBP) Ownership
ASBP ownership summary
as of October 18, 2026- Institutions
- 5.3% of shares outstanding
- Insiders
- 20.10% of shares outstanding
- Shares outstanding
- 1.4M
- Float
- 1.1M shares available to trade
- Short interest
- 0.98% 14K shares short
- Days to cover
- 0.37 short interest down 60.8% vs prior month
- Institutions 5.34%
- Insiders 20.10%
- Other investors 74.56%
ASBP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jane Street Group LLC | 1.06% | 15K | $130,207 | +14,830 (0.0%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.75% | 10K | $91,962 | +9,028 (+624.3%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.74% | 10K | $91,382 | +10,146 (+3,872.5%) | June 30, 2026 |
| 4 | Vanguard Fiduciary Trust Co | 0.72% | 10K | $88,511 | +9,986 (+10,511.6%) | June 30, 2026 |
| 5 | Crewe Advisors LLC | 0.05% | 677 | $5,944 | −1 (−0.1%) | June 30, 2026 |
| 6 | Tower Research Capital LLC | 0.02% | 283 | $2,485 | +211 (+293.1%) | June 30, 2026 |
| 7 | The Toronto-Dominion Bank | 0.01% | 166 | $1,457 | +166 (0.0%) | June 30, 2026 |
| 8 | Mercer Global Advisors Inc. | <0.01% | 3 | $26 | +3 (0.0%) | June 30, 2026 |
| 9 | SBI Securities Co Ltd | <0.01% | 2 | $18 | +2 (0.0%) | June 30, 2026 |
| 10 | Barclays PLC | <0.01% | 1 | $9 | +1 (0.0%) | June 30, 2026 |
| 11 | UBS Group AG | <0.01% | 1 | $9 | −6,382 (−100.0%) | June 30, 2026 |
| 12 | VR Advisory Services Ltd | 0.00% | — | — | −2,435 (−100.0%) | March 31, 2026 |
| 13 | Three Seasons Wealth, LLC | 0.00% | — | — | −3,125 (−100.0%) | March 31, 2026 |
| 14 | Valley Wealth Managers, Inc. | 0.00% | — | — | −1,000 (−100.0%) | March 31, 2026 |
| 15 | Allred Capital Management, LLC | 0.00% | — | — | −280 (−100.0%) | March 31, 2026 |
| 16 | Optivise Advisory Services LLC | 0.00% | — | — | −8,934 (−100.0%) | March 31, 2026 |
| 17 | Scientech Research LLC | 0.00% | — | — | −1,290 (−100.0%) | March 31, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −2,565 (−100.0%) | June 30, 2026 |
| 19 | Advisor Group Holdings, Inc. | 0.00% | — | — | — | June 30, 2026 |
| 20 | Platform Technology Partners | 0.00% | — | — | −940 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 44K shares and 10 cut 27K.
ASBP top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.63% | 8,813 | $77,378 | +1,925 (+27.9%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | 0.18% | 2,457 | $21,572 | — | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.12% | 1,745 | $15,321 | +1,698 (+3,612.8%) | August 31, 2026 |
| 4 | Fidelity Nasdaq Composite Index | 0.08% | 1,067 | $9,368 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ASBP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ASBP
Institutional investors own 5.3% of Aspire BioPharma's shares and insiders 20.10%. The largest holder is Jane Street Group LLC with 1.06% of the shares (15K), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 10 reduced their stake in the latest filings. Short interest is 0.98% of the float, or 0.37 days of average trading volume. The share count rose 119.0% since 2021.
Related: ASBP key metrics. See the ASBP stock overview for the latest quote and news.
ASBP ownership FAQ
Who owns the most Aspire BioPharma stock?
The largest shareholders of Aspire BioPharma are Jane Street Group LLC (1.06%), Geode Capital Management, LLC (0.75%), Vanguard Capital Management, LLC (0.74%), Vanguard Fiduciary Trust Co (0.72%), Crewe Advisors LLC (0.05%).
What percentage of Aspire BioPharma is owned by institutions?
Institutions hold 5.3% of Aspire BioPharma's shares outstanding; insiders hold 20.10%.
Which funds own Aspire BioPharma?
The largest fund holders of Aspire BioPharma are Fidelity Extended Market Index (0.63%), Fidelity Series Total Market Index (0.18%), Fidelity Total Market Index (0.12%), Fidelity Nasdaq Composite Index (0.08%).
What is Aspire BioPharma's short interest?
14K shares of Aspire BioPharma were sold short, 0.98% of the float; at the average daily volume it would take 0.37 days to cover.
How many shares of Aspire BioPharma are outstanding?
Aspire BioPharma has 1.4M shares outstanding, of which 1.1M are in the public float.